Operational forecasting for patients who are eligible for gene therapies will be crucial for addressing the accessibility and affordability challenges with these agents, especially as more gene therapies are expected to enter the market in the next few years.
Chelsee Jensen, PharmD, BCPS, of Mayo Clinic, commented on the recent FDA biosimilar approvals and what they mean for the industry's future, as well as how to ensure biosimilars are accessible to all patients.
Anita Allen, PhD, professor of law and philosophy, University of Pennsylvania, discusses the impact of abortion regulations in different parts of the world on women's reproductive access and rights, as well as the repercussions of the Dobbs decision that overturned Roe v Wade.
The landscape for biologics to treat patients with psoriasis looks excellent, said April Armstrong, MD, MPH, professor and chief of dermatology at UCLA.
During a session at AMCP Nexus, panelists provided a historical overview on the 340B drug discount program, highlighting the intentions of the plan and the research gaps leading to misconceptions about the program and whether it’s working to lower costs for patients.
Speakers at AMCP Nexus 2023 reviewed the major changes resulting from the Inflation Reduction Act (IRA) that impacted Medicare in 2023 and previewed the new provisions being implemented in the coming years.
Kristen Whelchel, PharmD, CSP, of Vanderbilt University Medical Center, details what services medically integrated dispensing (MID) specialty pharmacies provide.
In the aftermath of the Dobbs v Jackson Women’s Health Organization ruling, Anita Allen, PhD, highlights the challenges to abortion rights in the United States, emphasizing disparities faced by marginalized communities, outlining threats to reproductive health care, and calling for collective action and advocacy to defend constitutional privacy and uphold the dignity of all individuals.
Pawel Sobczuk, MD, PhD, of the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, previews the upcoming ESMO Congress 2023 in Madrid, Spain.
Two posters presented at the American Society for Reproductive Medicine 2023 Scientific Congress & Expo address racial and socioeconomic factors that impact fertility and birth outcomes.
At AMCP Nexus, Evernorth's Aimee Tharaldson, PharmD, provided an overview of which medications the FDA has approved in 2023 and what’s to come in nononcology areas over the next 5 years, including new drugs for Alzheimer disease, hemophilia, and nonalcoholic steatohepatitis (NASH).
During ESMO Congress 2023, sessions will focus on hot topics in therapeutic areas, such as the use of immunotherapies in both the neoadjuvant and adjuvant settings, as well as nontherapeutic topics, such as the needs of caregivers and advances in technology.
Jeff McIntyre, MA, of the Global Liver Institute, discussed how the delayed diagnosis of nonalcoholic steatohepatitis (NASH) affects patients and how health care and managed care professionals can help expedite diagnosis and treatment.
Kimberly Westrich, MA, of Cencora, explains how US payers' views and uses of value assessment tools have evolved.
Panelists at AMCP Nexus provided an overview of the US obesity epidemic, dispelling myths about the causes of obesity, highlighting racial and economic disparities across the nation, and tackling how the managed care space can ensure accessibility to care for all patients.
"The racial and ethnic distribution of United States sperm donors differs significantly from the United States population, particularly for those of African American or Black descent,” Cassie Hobbs, MD, explained.
This group of cancers remains a challenge to diagnose, can be rapidly progressive, and requires complex treatment and follow-up care, research suggests.
Two posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo showed trends in funding and insurance coverage for individuals seeking fertility care.
Ben Urick, PharmD, PhD, of Prime Therapeutics, compares the value of medically integrated specialty pharmacies with that of mail order pharmacies.
A session at AMCP Nexus on the use of artificial intelligence (AI) and machine learning (ML) in managed care highlights some real-world examples of successful implementation of these technologies.
Wiyatta Fahnbulleh, PsyD, and Pamela Blackwell, PsyD, LMSW, presented on the cultural limitations of the Personality Assessment Inventory and Minnesota Multiphasic Personality Inventory for assessing individuals for third-party reproduction.
A 2022 yearlong initiative at Summa Health Cancer Institute saw 100% of its patients with head and neck cancer undergoing radiation treatment referred to an oncology dietician for nutritional support and/or speech and swallow therapy.
Joseph Chervenak, MD, MBA, obstetrician and gynecologist, Montefiore Institute for Reproductive Medicine and Health, breaks down the benefits and challenges associated with implementing large language models such as ChatGPT into reproductive medicine and fertility care.
Nearly 50% of pregnancies worldwide are unplanned, leading to significant health, economic, and environmental consequences, Stephanie Page, MD, PhD, explains in her presentation at the American Society for Reproductive Medicine 2023 Scientific Congress & Expo.
The 2023 Fall Clinical Dermatology conference will take place in Las Vegas and be livestreamed from October 19 to 22; topics of interest to be covered include atopic dermatitis (AD), Janus kinase (JAK) inhibitors, and psoriasis.
Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, gives a preview of his session on mild to moderate atopic dermatitis (AD) in skin of color.
David Adamson, MD, FRCSC, FACOG, FACS, reproductive endocrinologist, surgeon, founder and CEO of ARC Fertility, and past president of The American Society for Reproductive Medicine, discusses the importance of professional guidelines in reproductive medicine.
According to the National Cancer Institute, in the year following a cancer diagnosis, the average cost of medical care plus medication exceeds $42,000, with some treatments having a price tag of more than $1 million.
The American Society of Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo in New Orleans will focus on the latest advancements and challenges in reproductive health, including new treatments and technology, evolving legislation, and the importance of professional guidelines.
Jennifer Mathieu, MA, senior vice president of professional and government affairs of the Academy of Managed Care Pharmacy (AMCP), described what is in store for attendees during next week's AMCP Nexus meeting.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
